Home Featured

Featured

Random

Optimi Health Announces Canadian Retail and E-Commerce Distribution Agreements for Functional Mushroom Supplements and Appoints Chief Financial Officer to its Board of Directors

Terran Biosciences announces publication of PCT patent application covering novel non-hallucinogenic psychoplastogens, including derivatives of DMT and ibogaine with improved pharmacokinetics and engagement at...

PT434 – Kiyumí Retreats, Building Somatic Literacy, and Navigating Group Facilitation Challenges

Clearmind Medicine Announces Closing of US$7.5 Million Public Offering and Uplisting to the Nasdaq Capital Market

Numinus to Present at the Small Cap Growth Virtual Investor Conference on July 13, 2023

PTSF81 – Somatics, Reframing Trauma, and the 7 Lens Approach, with...

PT251 – Kristina & Jonas of the Psychedelic Literacy Fund –...

Red Light Holland Sells Approximately 350,000 Grams of Magic Truffles and...

MYND Life Sciences Expands Intellectual Portfolio to Target Alzheimer’s disease and...

Mydecine to Launch Special Access Support and Supply Program in Canada...

Ian Burnstein Joins Wesana Health Advisory Board

Psychedelic Literacy for Veterans: Bridging the Knowledge Gap in PTSD Recovery

Numinus Wellness Graduates to Tier 1 on the TSX Venture Exchange

Women’s Health and Psychedelics – New Insights

Psychedelics 2022: A Year in Review

12 3...289 Page 1 of 289

Psychedelic Bulletin #200: Can Czechia Deliver on Psilocybin Access? A Closer...

The Backyard Psychedelic Renaissance: How Bottom-Up Change Is Delivering Psychedelic Access

Dreamshadow Transpersonal Breathwork

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.